(Q40524114)

21 September 2017

title

The modulation of tumour-versus-host response in lung, colon, and breast cancer patients: implications for adjuvant immunochemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A273408

14 February 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A273408

14 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

14 February 2023

author name string

A. M. Steward

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A273408

14 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=273408

14 February 2023

publication date

1 October 1977

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-2197.1977.tb06596.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

14 February 2023

published in

ANZ Journal of Surgery

1 reference

21 September 2017

volume

47

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

642-647

1 reference

Cell mediated immunity: separation of cells involved in recognitive and destructive phases

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.

14 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.

14 February 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer

14 February 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Stress Effect of Antilymphocyte Serum

14 February 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Cellular and Humoral immunity to Different Types of Human Neoplasms

14 February 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

14 February 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia

14 February 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Suppression of the tuberculin response in malignant disease

14 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma

14 February 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil

14 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

14 February 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

14 February 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Tuberculin-induced mitosis in peripheral blood leucocytes

14 February 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Salt Extraction of Soluble HL-A Antigens

14 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Tuberculin reaction in cancer patients, "Mantoux release," and lymphosuppressive-stimulatory factors.

14 February 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Circulating carcinoembryonic antigen levels and serum suppression of phytohemagglutinin-stimulated lymphocyte DNA synthesis: an inverse correlation in the cancer patient

14 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress

14 February 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Immunochemotherapy of lung cancer

14 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Lymphocyte Stimulation by Soluble Human HL-A Transplantation Antigens

14 February 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens

14 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1977.TB06596.X

14 February 2023

Identifiers

0 references

1 reference